BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21178048)

  • 1. Recurrence in the thyroidectomy bed: sonographic findings.
    Kamaya A; Gross M; Akatsu H; Jeffrey RB
    AJR Am J Roentgenol; 2011 Jan; 196(1):66-70. PubMed ID: 21178048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US diagnosis of cervical recurrence in patients operated on thyroid cancer: sonographic features and clinical significance.
    Lee YH; Lee NJ; Kim JH; Song JJ
    Auris Nasus Larynx; 2007 Jun; 34(2):213-9. PubMed ID: 17270376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off value for needle washout thyroglobulin in athyrotropic patients.
    Lee YH; Seo HS; Suh SI; Lee NJ; Kim JH; Seol HY; Lee JH; Kwon SY; Kim NH; Seo JA; Yang KS
    Laryngoscope; 2010 Jun; 120(6):1120-4. PubMed ID: 20513027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-needle aspiration biopsy of thyroid bed lesions in post-thyroidectomy patients: what is the importance of nondiagnostic biopsy results?
    Zini C; Thomas S; Raad R; White B; Antic T; Cohen R; Oto A
    J Ultrasound Med; 2012 Dec; 31(12):1973-6. PubMed ID: 23197550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray-scale and color Doppler ultrasonographic manifestations of papillary thyroid carcinoma: analysis of 51 cases.
    Yuan WH; Chiou HJ; Chou YH; Hsu HC; Tiu CM; Cheng CY; Lee CH
    Clin Imaging; 2006; 30(6):394-401. PubMed ID: 17101408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of thyroglobulin measurements in fine-needle aspirates of space occupying lesions in the thyroid bed after thyroid cancer operations.
    Suh YJ; Son EJ; Moon HJ; Kim EK; Han KH; Kwak JY
    Thyroid; 2013 Mar; 23(3):280-8. PubMed ID: 22950788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.
    Kim TY; Kim WB; Kim ES; Ryu JS; Yeo JS; Kim SC; Hong SJ; Shong YK
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1440-5. PubMed ID: 15613412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurthle cell neoplasms of the thyroid: sonographic appearance and histologic characteristics.
    Maizlin ZV; Wiseman SM; Vora P; Kirby JM; Mason AC; Filipenko D; Brown JA
    J Ultrasound Med; 2008 May; 27(5):751-7; quiz 759. PubMed ID: 18424651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonographic findings in the surgical bed after thyroidectomy: comparison of recurrent tumors and nonrecurrent lesions.
    Shin JH; Han BK; Ko EY; Kang SS
    J Ultrasound Med; 2007 Oct; 26(10):1359-66. PubMed ID: 17901139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Sonographic Characteristics of Thyroid Bed Lesions Identified Following Thyroidectomy in the Diagnosis or Exclusion of Recurrent Cancer.
    Frates MC; Parziale MP; Alexander EK; Barletta JA; Benson CB
    Radiology; 2021 May; 299(2):374-380. PubMed ID: 33650902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values.
    Kloos RT
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5241-8. PubMed ID: 20843945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
    Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
    Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
    Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
    Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
    Ma C; Xie J; Kuang A
    J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.